Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 37% ± 19% | |
lung | 10 studies | 26% ± 8% | |
eye | 7 studies | 27% ± 6% | |
peripheral blood | 5 studies | 19% ± 3% | |
heart | 5 studies | 29% ± 6% | |
kidney | 4 studies | 21% ± 5% | |
liver | 4 studies | 35% ± 12% | |
adipose | 4 studies | 28% ± 8% | |
intestine | 3 studies | 21% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 972.80 | 459 / 459 | 100% | 34.15 | 1118 / 1118 |
esophagus | 100% | 850.11 | 1445 / 1445 | 100% | 17.88 | 183 / 183 |
kidney | 100% | 947.13 | 89 / 89 | 100% | 27.03 | 901 / 901 |
ovary | 100% | 661.25 | 180 / 180 | 100% | 35.77 | 430 / 430 |
pancreas | 100% | 416.14 | 328 / 328 | 100% | 25.37 | 178 / 178 |
prostate | 100% | 845.33 | 245 / 245 | 100% | 34.62 | 502 / 502 |
stomach | 100% | 639.45 | 359 / 359 | 100% | 20.11 | 286 / 286 |
thymus | 100% | 968.20 | 653 / 653 | 100% | 40.01 | 605 / 605 |
uterus | 100% | 825.14 | 170 / 170 | 100% | 34.86 | 459 / 459 |
skin | 100% | 906.94 | 1808 / 1809 | 100% | 32.26 | 472 / 472 |
brain | 100% | 618.41 | 2634 / 2642 | 100% | 27.51 | 705 / 705 |
lung | 100% | 719.89 | 576 / 578 | 100% | 29.98 | 1155 / 1155 |
intestine | 100% | 729.81 | 966 / 966 | 100% | 22.22 | 525 / 527 |
adrenal gland | 100% | 1018.62 | 258 / 258 | 100% | 28.16 | 229 / 230 |
liver | 100% | 546.50 | 225 / 226 | 100% | 24.11 | 406 / 406 |
bladder | 100% | 774.95 | 21 / 21 | 99% | 33.69 | 501 / 504 |
adipose | 100% | 909.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 29.68 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 65.72 | 29 / 29 |
spleen | 100% | 752.21 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 26.55 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.82 | 1 / 1 |
blood vessel | 100% | 1006.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 850.08 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1202.62 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 535.54 | 853 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032434 | Biological process | regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_1902306 | Biological process | negative regulation of sodium ion transmembrane transport |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0006893 | Biological process | Golgi to plasma membrane transport |
GO_2000009 | Biological process | negative regulation of protein localization to cell surface |
GO_0048227 | Biological process | plasma membrane to endosome transport |
GO_0015031 | Biological process | protein transport |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0055070 | Biological process | copper ion homeostasis |
GO_0055037 | Cellular component | recycling endosome |
GO_0005769 | Cellular component | early endosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0010008 | Cellular component | endosome membrane |
GO_0005768 | Cellular component | endosome |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005547 | Molecular function | phosphatidylinositol-3,4,5-trisphosphate binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0019871 | Molecular function | sodium channel inhibitor activity |
GO_0080025 | Molecular function | phosphatidylinositol-3,5-bisphosphate binding |
GO_0070300 | Molecular function | phosphatidic acid binding |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0043325 | Molecular function | phosphatidylinositol-3,4-bisphosphate binding |
Gene name | COMMD1 |
Protein name | COMM domain-containing protein 1 (Protein Murr1) Copper metabolism domain containing 1 |
Synonyms | C2orf5 MURR1 |
Description | FUNCTION: Proposed scaffold protein that is implicated in diverse physiological processes and whose function may be in part linked to its ability to regulate ubiquitination of specific cellular proteins. Can modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes by displacing CAND1; in vitro promotes CRL E3 activity and dissociates CAND1 from CUL1 and CUL2 . Promotes ubiquitination of NF-kappa-B subunit RELA and its subsequent proteasomal degradation. Down-regulates NF-kappa-B activity . Involved in the regulation of membrane expression and ubiquitination of SLC12A2 . Modulates Na(+) transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits and by promoting their ubiquitination presumably involving NEDD4L. Promotes the localization of SCNN1D to recycling endosomes . Promotes CFTR cell surface expression through regulation of its ubiquitination . Down-regulates SOD1 activity by interfering with its homodimerization . Plays a role in copper ion homeostasis. Involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes . Can bind one copper ion per monomer . May function to facilitate biliary copper excretion within hepatocytes. Binds to phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) . Involved in the regulation of HIF1A-mediated transcription; competes with ARNT/Hif-1-beta for binding to HIF1A resulting in decreased DNA binding and impaired transcriptional activation by HIF-1 . Negatively regulates neuroblastoma G1/S phase cell cycle progression and cell proliferation by stimulating ubiquitination of NF-kappa-B subunit RELA and NF-kappa-B degradation in a FAM107A- and actin-dependent manner . . |
Accessions | Q8N668 ENST00000311832.6 [Q8N668-1] ENST00000427417.1 H7C377 H7C169 ENST00000455659.1 ENST00000444166.1 H0Y7J4 ENST00000458337.5 |